AA
GOSS icon

ALPS Advisors’s Gossamer Bio GOSS Stock Holding History

ALPS Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,239
Closed -$261K – 1031
2025
Q3 		$261K Sell
1,239
-294
-19% -$51.8K ﹤0.01% 1000
2025
Q2 		$151K Buy
+1,533
New +$134K ﹤0.01% 1017
2022
Q2 		– Sell
-983
Closed -$682K – 1058
2022
Q1 		$682K Sell
983
-123
-11% -$94.9K 0.01% 358
2021
Q4 		$1M Sell
1,106
-58
-5% -$55.1K 0.01% 359
2021
Q3 		$1.17M Sell
1,164
-86
-7% -$63.3K 0.01% 373
2021
Q2 		$812K Sell
1,250
-467
-27% -$324K 0.01% 429
2021
Q1 		$1.27M Buy
1,717
+4
+0.2% +$3.23K 0.01% 372
2020
Q4 		$1.32M Buy
1,713
+504
+42% +$397K 0.01% 360
2020
Q3 		$1.2M Sell
1,209
-83
-6% -$88K 0.02% 320
2020
Q2 		$1.34M Sell
1,292
-209
-14% -$210K 0.02% 270
2020
Q1 		$1.22M Sell
1,501
-162
-10% -$169K 0.02% 252
2019
Q4 		$2.08M Buy
1,663
+20
+1% +$32.2K 0.02% 223
2019
Q3 		$2.21M Sell
1,643
-81
-5% -$129K 0.02% 206
2019
Q2 		$3.06M Buy
+1,724
New +$2.64M 0.02% 189

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

ALPS Advisors's GOSS Position: Q4 2025 in Review

ALPS Advisors sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 1,239 shares — an estimated $261K sold.

ALPS Advisors first reported a position in GOSS in Q2 2019 and held it in 14 quarters. The position peaked at $3.06M in Q2 2019. 192 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • ALPS Advisors reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
  • ALPS Advisors sold 1,239 Gossamer Bio shares in Q4 2025, an estimated $261K.
  • ALPS Advisors first reported a position in Gossamer Bio in Q2 2019 and held it in 14 quarters.
  • ALPS Advisors's Gossamer Bio position peaked at $3.06M in Q2 2019.
  • 192 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on ALPS Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.